Trichosporon: another yeast‐like organism responsible for immune reconstitution inflammatory syndrome in patients with hematological malignancy
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2309
Abstract: Trichosporon has recently emerged as a life‐threatening opportunistic fungal pathogen, notably in patients with hematological malignancy. Fungemia, sometimes associated with cutaneous lesions and/or pneumonitis, is the major clinical form. Here, we report two cases of… read more here.
Keywords: patients hematological; inflammatory syndrome; trichosporon; reconstitution inflammatory ... See more keywords
The outcome of COVID‐19 in patients with hematological malignancy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Medical Virology"
DOI: 10.1002/jmv.26576
Abstract: Abstract I have read with great interest the recently published paper by Yigenoglu et al. entitled, “The outcome of COVID‐19 in patients with hematological malignancy”. This article is protected by copyright. All rights reserved. read more here.
Keywords: covid patients; patients hematological; hematological malignancy; outcome covid ... See more keywords
Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-021-02393-8
Abstract: Managing anticoagulation in hematological malignancy patients with atrial fibrillation and thrombocytopenia is a clinical challenge with limited data. We aimed to identify anticoagulation management strategies and evaluate bleeding and thrombosis rates associated with each approach.… read more here.
Keywords: atrial fibrillation; anticoagulation; hematological malignancy; patients atrial ... See more keywords
Cutaneous presentation of disseminated cytomegalovirus infection in a non-transplant patient with hematological malignancy
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000028721
Abstract: Abstract Rationale: Cytomegalovirus (CMV) disease is relatively uncommon in nontransplant hematological patients. Moreover, cutaneous manifestations of CMV diseases have scarcely been reported and are probably under-recognized. Patient concerns: We describe a patient with large B-cell… read more here.
Keywords: hematological malignancy; infection; malignancy cutaneous; cutaneous presentation ... See more keywords
Risk of hematological malignancy in blood donors: A nationwide cohort study
Sign Up to like & getrecommendations! Published in 2020 at "Transfusion"
DOI: 10.1111/trf.16020
Abstract: There has been a concern that blood donations can increase the risk of hematological malignancies. We investigated if blood donations increase the risk of developing hematological malignancies, specifically acute lymphoblastic leukemia, acute myeloid leukemia (AML),… read more here.
Keywords: risk; risk hematological; malignancy blood; blood ... See more keywords
Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies
Sign Up to like & getrecommendations! Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-141749
Abstract: Patients with COVID-19 and underlying hematological malignancy seem to have a higher mortality rate compared with those patients without malignancy, however, the extent of such excess risk is unclear. We performed a systematic review of… read more here.
Keywords: patients hematological; current employment; malignancy; hematological malignancy ... See more keywords
“Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan”
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0267139
Abstract: Purpose COVID-19 infection resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began to spread across the globe in early 2020. Patients with hematologic malignancies are supposed to have an increased risk of mortality from… read more here.
Keywords: covid infection; hematological malignancy; infection; hematological malignancies ... See more keywords
Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
Sign Up to like & getrecommendations! Published in 2022 at "Infection and Drug Resistance"
DOI: 10.2147/idr.s374904
Abstract: Background This study aimed to identify risk factors for mortality and outcomes in hematological malignancy (HM) patients with bloodstream infection (BSI) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Methods A retrospective study was conducted at a… read more here.
Keywords: outcomes hematological; hematological malignancy; factors mortality; mortality ... See more keywords
The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1110325
Abstract: Hematological malignancy develops and applies various mechanisms to induce immune escape, in part through an immunosuppressive microenvironment. Adenosine is an immunosuppressive metabolite produced at high levels within the tumor microenvironment (TME). Adenosine signaling through the… read more here.
Keywords: ectonucleotidases cd39; cd39 cd73; cd73 cells; hematological malignancy ... See more keywords
TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12030724
Abstract: Background: Tumor protein 53 (TP53) is a tumor-suppressor gene and plays an essential role in apoptosis, cell cycle arrest, genomic stability, and DNA repair. Although it is the most often mutated gene in human cancer,… read more here.
Keywords: saudi arabia; tp53; hematological malignancy; analysis ... See more keywords